Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Atea Pharmaceuticals (AVIR) Shares Outstanding (Weighted Average) (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 1 years of Shares Outstanding (Weighted Average) data on record, last reported at $21.6 million in Q4 2020.

  • For Q4 2020, Shares Outstanding (Weighted Average) changed N/A year-over-year to $21.6 million; the TTM value through Dec 2020 reached $21.6 million, changed N/A, while the annual FY2020 figure was $21.6 million, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $21.6 million in Q4 2020 per AVIR's latest filing, up from $10.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $21.6 million in Q4 2020 and bottomed at $10.1 million in Q3 2020.